HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hearse, D. J. Articles by Braimbridge, M. V. Search for Related Content PubMed PubMed Citation Articles by Hearse, D. J. Articles by Braimbridge, M. V.

The Journal of Thoracic and Cardiovascular Surgery, Vol 81, 873-879, Copyright © 1981 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Protection of the myocardium during ischemic arrest. Dose-response curves for procaine and lignocaine in cardioplegic solutions

DJ Hearse, K O'Brien and MV Braimbridge

The dose-response curve of procaine or lignocaine (lidocaine) added to the St. Thomas' Hospital cardioplegic solution was investigated with an isolated working rat heart preparation. In the absence of any cold cardioplegic protection, hearts failed to recover after as little as 30 minutes of ischemia. A single infusion (20 degrees C) of the basic St. Thomas' Hospital cardioplegic solution allowed hearts to recover to 60% or more of their preischemic control aortic flow after a 120 minute period of ischemia. Addition of procaine to the cardioplegic solution either increased or reduced the apparent protective properties of the solution with a bell-shaped dose-response curve being obtained. The optimum procaine concentration was 0.05 mM/L. At this concentration the protection afforded by the St. Thomas' Hospital solution was increased by up to two thirds. Substitution of lignocaine for procaine resulted in a similar dose-response curve with its optimum also at 0.05 mM/L. If a similar optimum exists for the human heart, the doses in current clinical use would appear to be too high. These results argue for determining the dose-response characteristics of all substances used in cardioplegic solutions.

This article has been cited by other articles:

				S. Yamaguchi, G. Watanabe, S. Tomita, and S. Tabata Lidocaine-magnesium blood cardioplegia was equivalent to potassium blood cardioplegia in left ventricular function of canine heart Interactive CardioVascular and Thoracic Surgery, April 1, 2007; 6(2): 172 - 176. [Abstract] [Full Text] [PDF]

				G. P. Dobson and M. W. Jones Adenosine and lidocaine: a new concept in nondepolarizing surgical myocardial arrest, protection, and preservation J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 794 - 805. [Abstract] [Full Text] [PDF]

				D. J. Chambers Mechanisms and alternative methods of achieving cardiac arrest Ann. Thorac. Surg., February 1, 2003; 75(2): S661 - 666. [Abstract] [Full Text] [PDF]